Discover

OCGN
Ocugen, Inc.
1.48
16 x 1.48
1 x 1.50
bid
ask
-
0.05
3.27%
9 @ 07:13 AM
1.49 +0.01 (0.68%)
Ytd9.63%
1y59.83%
1.48
day range
1.56
0.90
52 week range
2.73
Open1.53Prev Close1.53Low1.48High1.56Mkt Cap501.01M
Vol5.77MAvg Vol7.82MEPS-0.24P/EN/AForward P/E-2.85
Beta3.77Short Ratio14.01Inst. Own27.53%DividendN/ADiv YieldN/A
Ex Div DateN/AEarning07-3050-d Avg1.44200-d Avg1.551yr Est6.25

OCGN News

Ocugen to Participate in Upcoming July Industry Conferences
globenewswire.com
Ocugen to Participate in Upcoming July Industry Conferences

MALVERN, Pa., July 01, 2026 (GLOBE NEWSWIRE) -- Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN),

benzinga.com
Canaccord Genuity Maintains Buy on Ocugen, Lowers Price Target to $11

Canaccord Genuity analyst Whitney Ijem maintains Ocugen (NASDAQ:OCGN) with a Buy and lowers the p

12 Health Care Stocks Moving In Tuesday's Intraday Session
benzinga.com
12 Health Care Stocks Moving In Tuesday's Intraday Session

Full Transcript: Ocugen Q1 2026 Earnings Call
benzinga.com
Full Transcript: Ocugen Q1 2026 Earnings Call

benzinga.com
Ocugen Q1 EPS $(0.06) Misses $(0.05) Estimate, Sales $1.533M Beat $540.000K Estimate

Ocugen (NASDAQ:OCGN) reported quarterly losses of $(0.06) per share which missed the analyst consens

GeneDx Holdings, Duolingo, Kosmos Energy And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
benzinga.com
GeneDx Holdings, Duolingo, Kosmos Energy And Other Big Stocks Moving Lower In Tuesday's Pre-Market S

Dow futures up 100 pts. Shares of GeneDx Holdings (WGS) down 39.2% after cutting FY26 sales guidance

Earnings Scheduled For May 5, 2026
benzinga.com
Earnings Scheduled For May 5, 2026

12 Health Care Stocks Moving In Monday's After-Market Session
benzinga.com
12 Health Care Stocks Moving In Monday's After-Market Session

benzinga.com
Ocugen Plans To Commence $115M Senior Notes Offering

Ocugen, Inc. ("Ocugen" or the "Company") (NASDAQ:OCGN), a pioneering biotechnology l

benzinga.com
HC Wainwright & Co. Maintains Buy on Ocugen, Raises Price Target to $10

HC Wainwright & Co. analyst Swayampakula Ramakanth maintains Ocugen (NASDAQ:OCGN) with a Buy

Ocugen Eye Disease Gene Therapy Data Trails Earlier Results, Stocks Falls
benzinga.com
Ocugen Eye Disease Gene Therapy Data Trails Earlier Results, Stocks Falls

Ocugen stock falls after Phase 2 OCU410 data for dry AMD trails interim results, despite lesion redu

benzinga.com
Ocugen's 12-month Data From Phase 2 ArMaDa trial of OCU410 (AAV5-RORA) For Geographic Atrophy Second

Optimal dose intended for Phase 3 demonstrates statistically significant reduction in lesion growth

benzinga.com
Canaccord Genuity Initiates Coverage On Ocugen with Buy Rating, Announces Price Target of $12

Canaccord Genuity analyst Whitney Ijem initiates coverage on Ocugen (NASDAQ:OCGN) with a Buy rati

Why Is Ocugen Stock Soaring Today?
benzinga.com
Why Is Ocugen Stock Soaring Today?

Ocugen shares are surging Wednesday afternoon after Oppenheimer analyst Leland Gershell initiated co

12 Health Care Stocks Moving In Wednesday's Intraday Session
benzinga.com
12 Health Care Stocks Moving In Wednesday's Intraday Session

Serve Robotics Posts Upbeat Q4 Results, Joins Auna, Acacia Research And Other Big Stocks Moving Higher On Wednesday
benzinga.com
Serve Robotics Posts Upbeat Q4 Results, Joins Auna, Acacia Research And Other Big Stocks Moving High

Dow falls 200+ points as Serve Robotics Inc (NASDAQ: SERV) shares rise 16.2% on better-than-expected

This Ligand Pharmaceuticals Analyst Begins Coverage On A Bullish Note; Here Are Top 4 Initiations For Wednesday
benzinga.com
This Ligand Pharmaceuticals Analyst Begins Coverage On A Bullish Note; Here Are Top 4 Initiations Fo

Top Wall Street analysts changed outlook on top names. For all analyst rating changes, see analyst r

benzinga.com
Oppenheimer Initiates Coverage On Ocugen with Outperform Rating, Announces Price Target of $10

Oppenheimer analyst Leland Gershell initiates coverage on Ocugen (NASDAQ:OCGN) with a Outperform

Earnings Summary: Ocugen Q4
benzinga.com
Earnings Summary: Ocugen Q4

benzinga.com
Ocugen Q4 EPS $(0.06), Inline, Sales $(193.000K) Miss $860.000K Estimate

Ocugen (NASDAQ:OCGN) reported quarterly losses of $(0.06) per share which met the analyst consensus

Earnings Scheduled For March 4, 2026
benzinga.com
Earnings Scheduled For March 4, 2026

Examining the Future: Ocugen's Earnings Outlook
benzinga.com
Examining the Future: Ocugen's Earnings Outlook

benzinga.com
Ocugen Completes Enrollment In Late-Stage Blindness Trial, Eyes FDA Filing In 2026

Ocugen, Inc. (Ocugen or the Company) (NASDAQ:OCGN), a pioneering biotechnology leader in gene therap

Ocugen (OCGN) Stock Tumbles After $22.5 Million Share Offering
benzinga.com
Ocugen (OCGN) Stock Tumbles After $22.5 Million Share Offering

Ocugen shares sank sharply Wednesday after the biotech company announces a $22.5 million underwritte

Ocugen Stock Is Surging Today: What's Driving The Action?
benzinga.com
Ocugen Stock Is Surging Today: What's Driving The Action?

Ocugen Inc (NASDAQ:OCGN) shares are up on Friday as the company is gaining traction following positi

Ocugen's Early Gene Therapy Data Shows 46% Drop In Vision Damage
benzinga.com
Ocugen's Early Gene Therapy Data Shows 46% Drop In Vision Damage

Ocugen reports early phase 2 data showing its eye gene therapy reduced lesion growth by up to 54%, w

OS Therapies Bone Cancer Trial Data Strengthens FDA Case
benzinga.com
OS Therapies Bone Cancer Trial Data Strengthens FDA Case

OS Therapies releases trial data supporting FDA approval, U.K. and U.S. timelines, and potential eli

benzinga.com
Ocugen Announces Preliminary 12-Month Data From Phase 2 ArMaDa Clinical Trial Evaluating OCU410 For

Phase 2 (~50% of patients evaluated to date at 12 months) shows 46% lesion growth reduction vs. cont

benzinga.com
Ocugen Announces Publication Of Positive Phase 1 Gardian1 Trial Results For OCU410ST, Modifier Gene

Study supports favorable safety and tolerability profile and clinically meaningful functional and st

benzinga.com
Ocugen Q3 Sales $1.752M Beat $550.000K Estimate

Ocugen (NASDAQ:OCGN) reported quarterly sales of $1.752 million which beat the analyst consensus est

Earnings Scheduled For November 5, 2025
benzinga.com
Earnings Scheduled For November 5, 2025

benzinga.com
Forecasting The Future: 4 Analyst Projections For Ocugen

benzinga.com
12 Health Care Stocks Moving In Wednesday's After-Market Session

Ocugen Shares Are Trading Higher Monday: What's Going On?
benzinga.com
Ocugen Shares Are Trading Higher Monday: What's Going On?

Ocugen shares are trading higher Monday after the company announced a licensing agreement with Kwang

benzinga.com
Earnings Scheduled For August 1, 2025

Marriott International To Rally More Than 17%? Here Are 10 Top Analyst Forecasts For Monday
benzinga.com
Marriott International To Rally More Than 17%? Here Are 10 Top Analyst Forecasts For Monday

benzinga.com
Earnings Scheduled For May 9, 2025

benzinga.com
Earnings Scheduled For March 5, 2025

benzinga.com
Vanda Pharmaceuticals And Other Big Stocks Moving Lower In Thursday's Pre-Market Session

benzinga.com
Why Perficient Shares Are Trading Higher By Around 53%? Here Are 20 Stocks Moving In Monday's Mid-Da

benzinga.com
Why Clever Leaves Holdings Shares Are Trading Lower By Around 60%? Here Are Other Stocks Moving In M

benzinga.com
12 Health Care Stocks Moving In Friday's Intraday Session

benzinga.com
Signet Jewelers, Dave & Buster's Entertainment, Blue Owl Capital And Other Big Stocks Moving Higher

U.S. stocks were higher, with the Dow Jones gaining over 50 points on Wednesday.

benzinga.com
Why Landos Biopharma Shares Are Trading Higher By Over 170%? Here Are Other Stocks Moving In Monday'

Shares of Landos Biopharma, Inc. (NASDAQ: LABP) rose sharply during Monday’s session following acqu

benzinga.com
Why Cutera Shares Are Trading Lower By Over 26%? Here Are Other Stocks Moving In Friday's Mid-Day Se

Shares of Cutera, Inc. (NASDAQ: CUTR) fell sharply during Friday’s session after the company report

benzinga.com
Why Freshpet Shares Are Trading Higher By Around 15%? Here Are Other Stocks Moving In Monday's Mid-D

Shares of Freshpet, Inc. (NASDAQ: FRPT) gained 15.5% to $106.29 after the company reported better-t

benzinga.com
Why Fluor Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Tuesday's Mid-Day S

Shares of Fluor Corporation (NYSE: FLR) fell during Tuesday’s session following fourth-quarter resu

benzinga.com
Earnings Scheduled For November 9, 2023

Companies Reporting Before The Bell • Indivior (NASDAQ:INDV) is expected to report quarterly earnin

benzinga.com
Stocks That Hit 52-Week Lows On Tuesday

  During Tuesday's session, 275 companies made new 52-week lows.

benzinga.com
Ocugen And 2 Other Stocks Under $2 Insiders Are Aggressively Buying

The Dow Jones closed lower by over 100 points on Friday. When insiders purchase or sell shares, it i